14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.14 $1.32 Wednesday, 24th Apr 2024 ACRS stock ended at $1.17. This is 4.10% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 8.33% from a day low at $1.14 to a day high of $1.24.
90 days $1.05 $1.51
52 weeks $0.590 $11.12

Historical Aclaris Therapeutics prices

Date Open High Low Close Volume
Apr 27, 2022 $14.11 $14.12 $13.36 $13.39 542 787
Apr 26, 2022 $15.13 $15.37 $13.98 $14.07 287 816
Apr 25, 2022 $14.98 $15.33 $14.78 $15.28 265 404
Apr 22, 2022 $15.06 $15.16 $14.81 $15.10 166 789
Apr 21, 2022 $15.82 $15.82 $14.93 $15.05 386 700
Apr 20, 2022 $16.36 $16.36 $15.58 $15.82 215 700
Apr 19, 2022 $16.10 $16.51 $15.84 $16.27 141 700
Apr 18, 2022 $16.85 $17.00 $15.83 $16.10 374 900
Apr 14, 2022 $15.65 $17.07 $15.56 $17.01 267 959
Apr 13, 2022 $15.64 $15.91 $15.20 $15.68 305 009
Apr 12, 2022 $16.13 $16.37 $15.34 $15.53 202 264
Apr 11, 2022 $15.30 $16.00 $15.15 $15.90 735 132
Apr 08, 2022 $16.12 $16.31 $15.01 $15.41 445 200
Apr 07, 2022 $17.07 $17.08 $16.14 $16.18 225 400
Apr 06, 2022 $16.60 $17.16 $16.40 $16.89 544 700
Apr 05, 2022 $17.09 $17.47 $16.74 $16.77 517 900
Apr 04, 2022 $16.96 $17.45 $16.69 $17.08 370 100
Apr 01, 2022 $17.24 $17.68 $16.65 $16.91 324 831
Mar 31, 2022 $17.54 $17.86 $17.16 $17.24 196 812
Mar 30, 2022 $17.85 $18.59 $17.61 $17.64 348 994
Mar 29, 2022 $17.83 $18.08 $17.61 $17.85 731 200
Mar 28, 2022 $17.99 $18.20 $16.97 $17.64 227 600
Mar 25, 2022 $17.43 $18.15 $17.41 $17.92 282 300
Mar 24, 2022 $17.29 $17.66 $17.14 $17.64 323 500
Mar 23, 2022 $17.01 $17.37 $16.69 $17.27 363 500
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT